Ross Moat insider trades

Open-market stock purchases and sales by Ross Moat, CHIEF OPERATING OFFICER at Kiniksa Pharmaceuticals International, plc, from SEC Form 4 filings since Jul 15, 2021.

Recent trades

DateStockTradeValue
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcSold (not open market)$318K
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Sep 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 9, 2026KNSA Kiniksa Pharmaceuticals International, plcSold$79.5K
Apr 7, 2026KNSA Kiniksa Pharmaceuticals International, plcSold (not open market)$37.9K
Apr 7, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 6, 2026KNSA Kiniksa Pharmaceuticals International, plcSold$115K
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcSold (not open market)$82.1K
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Apr 1, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)—
Jan 15, 2026KNSA Kiniksa Pharmaceuticals International, plcBought (not open market)$21.2K

Companies traded

  • KNSA Kiniksa Pharmaceuticals International, plc: 11 sales, last Sep 1, 2026

Get free alerts when Ross Moat files a new trade →